Literature DB >> 15857325

The medicinal use of cannabis in the UK: results of a nationwide survey.

M A Ware1, H Adams, G W Guy.   

Abstract

The use of cannabis for medical purposes is a controversial but an important topic of public and scientific interest. We report on the results of a self-administered questionnaire study conducted in the United Kingdom between 1998 and 2002. The questionnaire consisted of 34 items and included demographic data, disease and medication use patterns and cannabis use profiles. Subjects were self-selected; 3663 questionnaires were distributed and 2969 were returned [1805 (60.9%) women, mean age 52.7 years (SD 12.7)]. Medicinal cannabis use was reported by patients with chronic pain (25%), multiple sclerosis and depression (22% each), arthritis (21%) and neuropathy (19%). Medicinal cannabis use was associated with younger age, male gender and previous recreational use (p < 0.001). While caution must be exercised in interpreting these data, they point to the need for clinical studies of cannabis and cannabinoids with standardised and quality-controlled products.

Entities:  

Mesh:

Year:  2005        PMID: 15857325     DOI: 10.1111/j.1742-1241.2004.00271.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  57 in total

1.  Exploring the ecological association between crime and medical marijuana dispensaries.

Authors:  Nancy J Kepple; Bridget Freisthler
Journal:  J Stud Alcohol Drugs       Date:  2012-07       Impact factor: 2.582

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Examining the relationship between the physical availability of medical marijuana and marijuana use across fifty California cities.

Authors:  Bridget Freisthler; Paul J Gruenewald
Journal:  Drug Alcohol Depend       Date:  2014-08-10       Impact factor: 4.492

Review 4.  In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.

Authors:  Rosalie Liccardo Pacula; Mireille Jacobson; Ervant J Maksabedian
Journal:  Addiction       Date:  2016-01-26       Impact factor: 6.526

Review 5.  The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.

Authors:  Roger G Pertwee
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

6.  Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.

Authors:  Francis Rodriguez Bambico; Noam Katz; Guy Debonnel; Gabriella Gobbi
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

7.  Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.

Authors:  Morouj Ismail; Ghada Khawaja
Journal:  Clin Rheumatol       Date:  2018-07-21       Impact factor: 2.980

8.  Characteristics of Individuals with Spinal Cord Injury Who Use Cannabis for Therapeutic Purposes.

Authors:  Claudia Drossel; Martin Forchheimer; Michelle A Meade
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

9.  Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Authors:  T V Zanelati; C Biojone; F A Moreira; F S Guimarães; Sâmia R L Joca
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

10.  The prevalence and incidence of medicinal cannabis on prescription in The Netherlands.

Authors:  Arno Hazekamp; Eibert R Heerdink
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.